Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma.

Richardson, P G; Hofmeister, C C; Raje, N S; Siegel, D S; Lonial, S; Laubach, J; Efebera, Y A; Vesole, D H; Nooka, A K; Rosenblatt, J; Doss, D; Zaki, M H; Bensmaine, A; Herring, J; Li, Y; Watkins, L; Chen, M S; Anderson, K C

Richardson, P G; Hofmeister, C C; Raje, N S; Siegel, D S; Lonial, S; Laubach, J; Efebera, Y A; Vesole, D H; Nooka, A K; Rosenblatt, J; Doss, D; Zaki, M H; Bensmaine, A; Herring, J; Li, Y; Watkins, L; Chen, M S; Anderson, K C.

Afiliación

Richardson PG; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. paul_richardson@dfci.harvard.edu.
Hofmeister CC; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Raje NS; Massachusetts General Hospital, Boston, MA, USA.
Siegel DS; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
Lonial S; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
Laubach J; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Efebera YA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Vesole DH; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
Nooka AK; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
Rosenblatt J; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Doss D; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Zaki MH; Celgene Corporation, Summit, NJ, USA.
Bensmaine A; Celgene Corporation, Summit, NJ, USA.
Herring J; Celgene Corporation, Summit, NJ, USA.
Li Y; Celgene Corporation, Summit, NJ, USA.
Watkins L; Celgene Corporation, Summit, NJ, USA.
Chen MS; Celgene Corporation, Summit, NJ, USA.
Anderson KC; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Leukemia ; 32(10): 2305, 2018 10.

Article en En | MEDLINE | ID: mdl-30218008

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google